Peakview Partners is pleased to announce that Altitude Control Technologies has been acquired by Altitude Control Technology, an acquisition-entity established by a Denver-based investment group. Peakview served as the exclusive M&A advisor to Altitude Control Technologies in this transaction.
Larry Kutt, Co-Founder and CEO of Altitude Control Technologies, said “We created a unique business model within the niche altitude simulation market. To successfully sell our business at a premium valuation, Peakview spent significant time and energy to fully understand our value proposition so they could effectively communicate that to the marketplace. They conducted a thorough marketing process to a broad range of potential buyers before finding the right fit, both economically and culturally. We don’t see how this transaction could have come together without Peakview’s diligent efforts. We couldn’t be more pleased.”
Altitude Control Technologies is the world’s leading provider of oxygenation systems to luxury mountain homes. The Company’s superior oxygenation product offers better sleep, more energy and elimination of altitude sickness for those staying in the mountains. The Company is also well-known for providing altitude simulation for the medical research, altitude sports training and aviation training markets globally. Clients include the Mayo Clinic, Harvard Medical School, professional sports teams and the US military, among many others.
Altitude Control Technology is backed by a Denver-based investment group with deep technology and operational expertise. Altitude Control Technology was established to acquireAltitude Control Technologies and continue its path of aggressive growth and leadership position in the altitude simulation market. Further information is available at www.altitudect.com.